Seoul, South Korea

Jungwon Keum

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Samsung Electronics Co., Ltd.. Active years: 2017-2018.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Yongin-si, KR (2017)
  • Seoul, KR (2018)

Company Filing History:


Years Active: 2017-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Jungwon Keum

Introduction

Jungwon Keum is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of genomic research, particularly in the area of telomere amplification and cellular senescence. With a total of 2 patents, his work has implications for both scientific research and potential therapeutic applications.

Latest Patents

Jungwon Keum's latest patents include a method of amplifying telomeres of genomic DNA using an adaptor sequence. This innovative approach also encompasses a composition and a kit designed for the amplification of telomeres. Additionally, he has developed a composition aimed at reducing senescence in cells or subjects, which includes a BRAF inhibitor. This method provides a means to treat or prevent symptoms or diseases associated with cellular aging.

Career Highlights

Jungwon Keum is currently employed at Samsung Electronics Co., Ltd., where he continues to push the boundaries of scientific innovation. His work at this leading technology company allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Hyuntae Kang and Joontae Park, who work alongside him in advancing their research initiatives.

Conclusion

Jungwon Keum's contributions to the field of genomic research highlight the importance of innovation in addressing complex biological challenges. His patents reflect a commitment to enhancing our understanding of cellular processes and developing potential therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…